Genetic Abnormalities in a Real-World Cohort of Multiple Myeloma (MM) Patients, and Their Impact on Outcomes: Single-Center Experience

被引：0
|
作者：
Vaitekenaite, Vilmante [1 ]
Peceliunas, Valdas [1 ]
机构：
[1] Vilnius Univ Hosp Santaros Klinikos, Hematol Oncol & Transfus Med Ctr, Vilnius, Lithuania
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
MM; single nucleotide polymorphism; real-world data;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MM-445
引用
收藏
页码：S499 / S500
页数：2
相关论文
共 50 条
  • [1] Real-World Clinical Outcomes in Elderly Chinese Patients with Multiple Myeloma: A Single-Center Experience
    Qian, Xifeng
    Chen, Heng
    Xia, Jun
    Wang, Jing
    Zhou, Xin
    Guo, Hongfeng
    [J]. MEDICAL SCIENCE MONITOR, 2018, 24 : 5887 - 5893
  • [2] Real-world experience of novel multiple myeloma treatments in a large, single-center cohort in Finland
    Loponen, Heidi
    Mehtala, Juha
    Ylisaukko-oja, Tero
    Bruck, Oscar
    Porkka, Kimmo
    Koskenvesa, Perttu
    Saukkonen, Kirsi
    Lievonen, Juha
    [J]. EJHAEM, 2023, 4 (04): : 1019 - 1029
  • [3] Vaccinations in patients with multiple sclerosis: a real-world, single-center, experience
    Sbragia, E.
    Olobardi, D.
    Giovanni, N.
    Lapucci, C.
    Boffa, G.
    Capello, E.
    Cellerino, M.
    Laroni, A.
    Sticchi, L.
    Inglese, M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 648 - 649
  • [4] Vaccinations in patients with multiple sclerosis: a real-world, single-center, experience
    Sbragia, E.
    Olobardi, D.
    Novi, G.
    Lapucci, C.
    Cellerino, M.
    Boffa, G.
    Laroni, A.
    Mikulska, M.
    Sticchi, L.
    Inglese, M.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 788 - 788
  • [5] Vaccinations in patients with multiple sclerosis: a real-world, single-center experience
    Sbragia, Elvira
    Olobardi, Dario
    Novi, Giovanni
    Lapucci, Caterina
    Cellerino, Maria
    Boffa, Giacomo
    Laroni, Alice
    Mikulska, Malgorzata
    Sticchi, Laura
    Inglese, Matilde
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (06)
  • [6] Retrospective, single-center, real-world experience of belantamab mafodotin in relapsed/refractory multiple myeloma
    Becnel, Melody
    Ferreri, Christopher
    Feng, Lei
    Richards, Tiffany
    Horowitz, Sandra
    Patel, Nimisha
    Gombos, Dan
    Razmandi, Azadeh
    Murga, Astrid
    Seif, Sherif
    Youssef, George
    Murphy, Kevin
    Kaufman, Gregory
    Weber, Donna
    Patel, Krina
    Thomas, Sheeba
    Manasanch, Elisabet
    Orlowski, Robert
    Lee, Hans
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S163 - S164
  • [7] Multiple myeloma (MM): Loss of patients per treatment line in a single real-world center
    Steinmetz, T.
    Bergmann, M.
    Heinz, M.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 115 - 116
  • [8] Real-World Experience with Emicizumab Prophylaxis in the Milan Cohort: A Single-Center Experience
    Arcudi, Sara
    Ciavarella, Alessandro
    Gualtierotti, Roberta
    Marino, Sonia
    Boscarino, Marco
    Siboni, Simona
    Biguzzi, Eugenia
    Schiavone, Lucia
    Novembrino, Cristina
    Valsecchi, Carla
    Peyvandi, Flora
    [J]. BLOOD, 2021, 138
  • [9] Real-world outcomes of secukinumab in psoriasis: a single-center experience in Taiwan
    Liu, C. -H.
    Lee, C. -N.
    Yang, C. -C.
    [J]. EXPERIMENTAL DERMATOLOGY, 2018, 27 : 47 - 47
  • [10] Ocrelizumab treatment in patients with progressive multiple sclerosis: a single-center real-world experience
    Cellerino, M.
    Boffa, G.
    Lapucci, C.
    Sbragia, E.
    Bruschi, N.
    Mancuso, E.
    Tazza, F.
    Poire, I.
    Laroni, A.
    Capello, E.
    Uccelli, A.
    Novi, G.
    Inglese, M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 295 - 295
12345